Windlas Biotech Ltd reported strong financial performance for Q4 FY25 with a revenue of INR 759 crores, showing a 20.4% year-on-year growth and a highest ever EPS of INR 29.19, alongside capacity expansion projects and strong liquidity of INR 213 crores.